Vanda Pharmaceuticals Inc Financial Flexibility Index
Vanda Pharmaceuticals Inc financial flexibility index. Vanda Pharmaceuticals Inc (VNDA) has a Financial Flexibility Index of -0.18x as of December 2025. Free cash flow of $-29.32 Million (operating CF $-29.42 Million minus capex $102.00K) represents 0% of total liabilities ($161.76 Million). See Vanda Pharmaceuticals Inc (VNDA) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Vanda Pharmaceuticals Inc (2004–2025)
Financial flexibility index of Vanda Pharmaceuticals Inc from 2004 to 2025. Historical Financial Flexibility Index trend for Vanda Pharmaceuticals Inc across 22 annual periods. Check Vanda Pharmaceuticals Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Vanda Pharmaceuticals Inc Financial Flexibility Index by Year (2004–2025)
Vanda Pharmaceuticals Inc financial flexibility index by year from 2004 to 2025. Year-by-year free cash flow to debt coverage for Vanda Pharmaceuticals Inc. For the full cash flow conversion analysis, see VNDA cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.67x | $-108.44 Million | $-109.44 Million | $161.76 Million | ▼ -416.7% |
| 2024 | -0.13x | $-15.27 Million | $-15.76 Million | $117.66 Million | ▼ -201.9% |
| 2023 | 0.13x | $13.18 Million | $12.80 Million | $103.53 Million | ▼ -58.3% |
| 2022 | 0.31x | $32.66 Million | $31.98 Million | $107.05 Million | ▼ -58.1% |
| 2021 | 0.73x | $64.77 Million | $64.21 Million | $88.86 Million | ▲ +9.1% |
| 2020 | 0.67x | $53.57 Million | $51.77 Million | $80.19 Million | ▲ +3.6% |
| 2019 | 0.65x | $46.97 Million | $45.95 Million | $72.80 Million | ▼ -33.9% |
| 2018 | 0.98x | $55.35 Million | $29.99 Million | $56.71 Million | ▲ +22755.2% |
| 2017 | 0.00x | $-319.00K | $-1.98 Million | $74.04 Million | ▲ +94.9% |
| 2016 | -0.08x | $-6.70 Million | $-8.10 Million | $79.04 Million | ▼ -145.3% |
| 2015 | 0.19x | $14.98 Million | $12.45 Million | $80.02 Million | ▲ +102.8% |
| 2014 | -6.69x | $-72.78 Million | $-81.55 Million | $10.89 Million | ▼ -1583.0% |
| 2013 | -0.40x | $-39.42 Million | $-39.59 Million | $99.22 Million | ▼ -16.2% |
| 2012 | -0.34x | $-42.90 Million | $-44.92 Million | $125.54 Million | ▼ -81.1% |
| 2011 | -0.19x | $-28.14 Million | $-28.41 Million | $149.14 Million | ▼ -203.6% |
| 2010 | -0.06x | $-10.90 Million | $-10.90 Million | $175.37 Million | ▼ -106.9% |
| 2009 | 0.89x | $181.34 Million | $169.34 Million | $202.68 Million | ▲ +107.8% |
| 2008 | -11.50x | $-45.01 Million | $-45.96 Million | $3.91 Million | ▼ -194.1% |
| 2007 | -3.91x | $-51.36 Million | $-51.64 Million | $13.13 Million | ▲ +26.1% |
| 2006 | -5.29x | $-50.27 Million | $-51.62 Million | $9.50 Million | ▼ -54.5% |
| 2005 | -3.42x | $-17.42 Million | $-17.71 Million | $5.09 Million | ▲ +24.5% |
| 2004 | -4.53x | $-8.20 Million | $-8.61 Million | $1.81 Million | — |